Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00586937 · ClinicalTrials.gov registry record

Quality of Life in Lung Cancer Survivors

A clinical trial of Lung Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
193
Enrollment target
1
Study location

NCT00586937 is a study of Lung Cancer Survivors that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 193 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00586937, a study of Lung Cancer Survivors, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
193 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.

Conditions Studied

Interventions

  • BEHAVIORAL questionnaires or telephone interview

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 193 participants
Start Date 2005-06
Est. Completion 2020-01-02

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00586937

The ClinicalTrials.gov registry entry for NCT00586937 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which questionnaires or telephone interview is the first listed.

NCT00586937 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00586937 about?

NCT00586937 is a clinical study titled "Quality of Life in Lung Cancer Survivors". The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, ...

What is the current status of trial NCT00586937?

This trial is currently completed. The enrollment target is 193 participants. The study started on 2005-06. Estimated completion is 2020-01-02.

What conditions does trial NCT00586937 study?

This clinical trial studies the following conditions: Lung Cancer Survivors.

What interventions are being tested in trial NCT00586937?

The interventions under investigation include: questionnaires or telephone interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT00586937?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00586937 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.